Exact Mass: 369.1899762

Exact Mass Matches: 369.1899762

Found 93 metabolites which its exact mass value is equals to given mass value 369.1899762, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Corydalin

(+)-Corydaline

C22H27NO4 (369.19399820000007)


D004791 - Enzyme Inhibitors Corydaline ((+)-Corydaline), an isoquinoline alkaloid isolated from Corydalis yanhusuo, is an AChE inhibitor with an IC50 of 226 μM. Corydaline is a μ-opioid receptor (Ki of 1.23 μM) agonist and inhibits enterovirus 71 (EV71) replication (IC50 of 25.23 μM). Corydaline has anti-angiogenic, anti-allergic and gastric-emptying and antinociceptive activities[1][2][3]. Corydaline ((+)-Corydaline), an isoquinoline alkaloid isolated from Corydalis yanhusuo, is an AChE inhibitor with an IC50 of 226 μM. Corydaline is a μ-opioid receptor (Ki of 1.23 μM) agonist and inhibits enterovirus 71 (EV71) replication (IC50 of 25.23 μM). Corydaline has anti-angiogenic, anti-allergic and gastric-emptying and antinociceptive activities[1][2][3]. Corydaline ((+)-Corydaline), an isoquinoline alkaloid isolated from Corydalis yanhusuo, is an AChE inhibitor with an IC50 of 226 μM. Corydaline is a μ-opioid receptor (Ki of 1.23 μM) agonist and inhibits enterovirus 71 (EV71) replication (IC50 of 25.23 μM). Corydaline has anti-angiogenic, anti-allergic and gastric-emptying and antinociceptive activities[1][2][3].

   

Thalicsessine

21-(2-Hydroxyethyl)-6,21-secohetisan-6,11,19-trione

C22H27NO4 (369.19399820000007)


   

Trimetrexate

5-methyl-6-{[(3,4,5-trimethoxyphenyl)amino]methyl}quinazoline-2,4-diamine

C19H23N5O3 (369.18008080000004)


A nonclassical folic acid inhibitor through its inhibition of the enzyme dihydrofolate reductase. It is being tested for efficacy as an antineoplastic agent and as an antiparasitic agent against pneumocystis pneumonia in AIDS patients. Myelosuppression is its dose-limiting toxic effect. [PubChem] P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D000890 - Anti-Infective Agents > D000935 - Antifungal Agents D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents Same as: D06238

   

5-Fluoro-3-[3-[4-(5-methoxypyrimidin-4-yl)piperazin-1-yl]propyl]-1H-indole

3-(3-(4-(5-Methoxy-4-pyrimidinyl)-1-piperazinyl)propyl)-5-fluoro-1H-indole hydrochloride

C20H24FN5O (369.1964786)


   

Corydalin

3,4,10,11-tetramethoxy-13-methyl-7,8,12b,13-tetrahydro-5H-6-azatetraphene

C22H27NO4 (369.19399820000007)


D004791 - Enzyme Inhibitors

   

Corydaline

6H-Dibenzo(a,g)quinolizine, 5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-13-methyl-, (13S-trans)- (9CI)

C22H27NO4 (369.19399820000007)


Corydaline is an isoquinoline alkaloid and a member of isoquinolines. Corydaline is a natural product found in Corydalis remota, Corydalis saxicola, and other organisms with data available. D004791 - Enzyme Inhibitors Corydaline ((+)-Corydaline), an isoquinoline alkaloid isolated from Corydalis yanhusuo, is an AChE inhibitor with an IC50 of 226 μM. Corydaline is a μ-opioid receptor (Ki of 1.23 μM) agonist and inhibits enterovirus 71 (EV71) replication (IC50 of 25.23 μM). Corydaline has anti-angiogenic, anti-allergic and gastric-emptying and antinociceptive activities[1][2][3]. Corydaline ((+)-Corydaline), an isoquinoline alkaloid isolated from Corydalis yanhusuo, is an AChE inhibitor with an IC50 of 226 μM. Corydaline is a μ-opioid receptor (Ki of 1.23 μM) agonist and inhibits enterovirus 71 (EV71) replication (IC50 of 25.23 μM). Corydaline has anti-angiogenic, anti-allergic and gastric-emptying and antinociceptive activities[1][2][3]. Corydaline ((+)-Corydaline), an isoquinoline alkaloid isolated from Corydalis yanhusuo, is an AChE inhibitor with an IC50 of 226 μM. Corydaline is a μ-opioid receptor (Ki of 1.23 μM) agonist and inhibits enterovirus 71 (EV71) replication (IC50 of 25.23 μM). Corydaline has anti-angiogenic, anti-allergic and gastric-emptying and antinociceptive activities[1][2][3].

   
   
   
   
   
   
   
   

2-benzamido-1-(4-methoxyphenyl)ethyl hexanoate|zanthorhetsamide

2-benzamido-1-(4-methoxyphenyl)ethyl hexanoate|zanthorhetsamide

C22H27NO4 (369.19399820000007)


   
   

didehydrotuberostemonine A|rel-(8R,8aS,11S,11aR)-8-ethyl-5,6,8,8a,11,11a-hexahydro-11-methyl-2-[(2S,4S)-tetrahydro-4-methyl-5-oxofuran-2-yl]azepino[3,2,1-hi]furo[3,2-e]indol-10(4H)-one

didehydrotuberostemonine A|rel-(8R,8aS,11S,11aR)-8-ethyl-5,6,8,8a,11,11a-hexahydro-11-methyl-2-[(2S,4S)-tetrahydro-4-methyl-5-oxofuran-2-yl]azepino[3,2,1-hi]furo[3,2-e]indol-10(4H)-one

C22H27NO4 (369.19399820000007)


   

(+)-Corydaline

(+)-Corydaline

C22H27NO4 (369.19399820000007)


Annotation level-1

   

PC(7:0/0:0)

3,5,9-Trioxa-4-phosphahexadecan-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, (R)-

C15H32NO7P (369.1916292)


   

PC(7:0/0:0)[U]

3,5,9-Trioxa-4-phosphahexadecan-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide

C15H32NO7P (369.1916292)


   

PC(0:0/7:0)

3,5,8-Trioxa-4-phosphapentadecan-1-aminium, 4-hydroxy-7-(hydroxymethyl)-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide, (R)-

C15H32NO7P (369.1916292)


   

PC(0:0/7:0)[U]

3,5,8-Trioxa-4-phosphapentadecan-1-aminium, 4-hydroxy-7-(hydroxymethyl)-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide

C15H32NO7P (369.1916292)


   

LPC 7:0

2-heptanoyl-sn-glycero-3-phosphocholine

C15H32NO7P (369.1916292)


   

2-(2-ethylhexyl)-6,7-dimethoxy-1H-benz[de]isoquinoline-1,3(2H)-dione

2-(2-ethylhexyl)-6,7-dimethoxy-1H-benz[de]isoquinoline-1,3(2H)-dione

C22H27NO4 (369.19399820000007)


   

(3-(carbazole-9H)Phenyl)Pinacol ester

(3-(carbazole-9H)Phenyl)Pinacol ester

C24H24BNO2 (369.1899994)


   

n(alpha) n-(im)-di-boc-l-histidine

n(alpha) n-(im)-di-boc-l-histidine

C17H27N3O6 (369.1899762)


   

ERYTHRO-N-BOC-O-BENZYL-L-TYROSINE EPOXIDE

ERYTHRO-N-BOC-O-BENZYL-L-TYROSINE EPOXIDE

C22H27NO4 (369.19399820000007)


   

9-Phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole

9-Phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole

C24H24BNO2 (369.1899994)


   

2-[4-(Dibutylamino)-2-hydroxybenzoyl]benzoic acid

2-[4-(Dibutylamino)-2-hydroxybenzoyl]benzoic acid

C22H27NO4 (369.19399820000007)


   

9-Phenyl-9H-carbazole-3-boronic acid pinacol ester

9-Phenyl-9H-carbazole-3-boronic acid pinacol ester

C24H24BNO2 (369.1899994)


   

Tetrabutylammonium iodide

Tetrabutylammonium iodide

C16H36IN (369.1892366)


D013501 - Surface-Active Agents > D003902 - Detergents

   

1-(4-AMINO-PHENYL)-AZETIDINE-3-CARBOXYLICACIDMETHYLESTER

1-(4-AMINO-PHENYL)-AZETIDINE-3-CARBOXYLICACIDMETHYLESTER

C23H28ClNO (369.18593080000005)


   

9-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-9H-carbazole

9-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-9H-carbazole

C24H24BNO2 (369.1899994)


   
   

5-Amino-1-Boc-3,4,5,6-tetrahydro-2H-[2,4]bipyridinyl oxalate

5-Amino-1-Boc-3,4,5,6-tetrahydro-2H-[2,4]bipyridinyl oxalate

C17H27N3O6 (369.1899762)


   
   

9H-fluoren-9-ylmethyl N-[(2S)-1-hydroxy-3-[(2-methylpropan-2-yl)oxy]propan-2-yl]carbamate

9H-fluoren-9-ylmethyl N-[(2S)-1-hydroxy-3-[(2-methylpropan-2-yl)oxy]propan-2-yl]carbamate

C22H27NO4 (369.19399820000007)


   

(4-Cyclobutyl-1,4-diazepan-1-yl)(6-(4-fluorophenoxy)pyridin-3-yl)methanone

(4-Cyclobutyl-1,4-diazepan-1-yl)(6-(4-fluorophenoxy)pyridin-3-yl)methanone

C21H24FN3O2 (369.1852456)


   

2-Amino-1-[2-(4-morpholinyl)ethyl]-3-pyrrolo[3,2-b]quinoxalinecarboxylic acid ethyl ester

2-Amino-1-[2-(4-morpholinyl)ethyl]-3-pyrrolo[3,2-b]quinoxalinecarboxylic acid ethyl ester

C19H23N5O3 (369.18008080000004)


   

D-Phenylalanyl-N-(3-Fluorobenzyl)-L-Prolinamide

D-Phenylalanyl-N-(3-Fluorobenzyl)-L-Prolinamide

C21H24FN3O2 (369.1852456)


   

trimetrexate

trimetrexate

C19H23N5O3 (369.18008080000004)


P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D000890 - Anti-Infective Agents > D000935 - Antifungal Agents D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents Same as: D06238

   

Strictosidine aglycone(1+)

Strictosidine aglycone(1+)

C21H25N2O4+ (369.181423)


Conjugate acid of strictosidine aglycone arising from deprotonation of the secondary amino group; major species at pH 7.3.

   
   

2-[(4,4-Dimethyl-2,6-dioxocyclohexyl)-(3-pyridinyl)methyl]-5,5-dimethylcyclohexane-1,3-dione

2-[(4,4-Dimethyl-2,6-dioxocyclohexyl)-(3-pyridinyl)methyl]-5,5-dimethylcyclohexane-1,3-dione

C22H27NO4 (369.19399820000007)


   

1-(2,6-Dimethylphenyl)-3-[[1-(4-methoxyphenyl)-3-pyrrolidinyl]methyl]thiourea

1-(2,6-Dimethylphenyl)-3-[[1-(4-methoxyphenyl)-3-pyrrolidinyl]methyl]thiourea

C21H27N3OS (369.18747320000006)


   

4-(9H-fluoren-9-yl)-N-phenyl-1-piperazinecarboxamide

4-(9H-fluoren-9-yl)-N-phenyl-1-piperazinecarboxamide

C24H23N3O (369.1841028)


   

N-(2-methyl-5-nitrophenyl)-4,6-bis(1-pyrrolidinyl)-1,3,5-triazin-2-amine

N-(2-methyl-5-nitrophenyl)-4,6-bis(1-pyrrolidinyl)-1,3,5-triazin-2-amine

C18H23N7O2 (369.1913138)


   

6,10-Dimethyl-N-(2-morpholin-4-ylethyl)-2-oxo-1,6,8-triazatricyclo[7.4.0.03,7]trideca-3(7),4,8,10,12-pentaene-5-carboxamide

6,10-Dimethyl-N-(2-morpholin-4-ylethyl)-2-oxo-1,6,8-triazatricyclo[7.4.0.03,7]trideca-3(7),4,8,10,12-pentaene-5-carboxamide

C19H23N5O3 (369.18008080000004)


   

Hoerhammericine(1+)

Hoerhammericine(1+)

C21H25N2O4+ (369.181423)


An ammonium ion derivative resulting from the protonation of the tertiary amino group of hoerhammericine. The major species at pH 7.3. Note that the stereoconfiguration of the epoxy group is based on CHEBI:144374, and of the 19 hydroxy group on CHEBI:144372 (the same enzyme produces the two).

   

1-(2,4-dimethylphenyl)-3-[(E)-[4-(3-methylbutoxy)phenyl]methylideneamino]thiourea

1-(2,4-dimethylphenyl)-3-[(E)-[4-(3-methylbutoxy)phenyl]methylideneamino]thiourea

C21H27N3OS (369.18747320000006)


   

[(1R,5S)-7-[4-(3-methylphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-pyridin-4-ylmethanone

[(1R,5S)-7-[4-(3-methylphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-pyridin-4-ylmethanone

C24H23N3O (369.1841028)


   

N-Ethyl-2,3,5,6-tetrahydro-4H,13H-15-oxa-3a,8-diaza-1H-dibenzo[a,hi]naphthacene-13-imine

N-Ethyl-2,3,5,6-tetrahydro-4H,13H-15-oxa-3a,8-diaza-1H-dibenzo[a,hi]naphthacene-13-imine

C24H23N3O (369.1841028)


   

1-Heptanoyl-2-hydroxy-sn-glycero-3-phosphocholine

1-Heptanoyl-2-hydroxy-sn-glycero-3-phosphocholine

C15H32NO7P (369.1916292)


   

[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] decanoate

[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] decanoate

C15H32NO7P (369.1916292)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octoxypropan-2-yl] acetate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octoxypropan-2-yl] acetate

C15H32NO7P (369.1916292)


   
   

1-heptanoyl-sn-glycero-3-phosphocholine

1-heptanoyl-sn-glycero-3-phosphocholine

C15H32NO7P (369.1916292)


   

2-heptanoyl-sn-glycero-3-phosphocholine

2-heptanoyl-sn-glycero-3-phosphocholine

C15H32NO7P (369.1916292)


A 2-acyl-sn-glycero-3-phosphocholine in which the acyl group is specified as heptanoyl.

   

LPE(10:0)

LPE(10:0)

C15H32NO7P (369.1916292)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   

VU0357017 (hydrochloride)

VU0357017 (hydrochloride)

C18H28ClN3O3 (369.1819088000001)


VU0357017 hydrochloride (CID-25010775) is a potent, selective and brain-penetrant allosteric agonist of M1 muscarinic acetylcholine receptor, with an EC50 of 477 nM. VU0357017 hydrochloride is highly selective for M1 and has no activity at M2-M5 up to the highest concentrations tested (30 μM). VU0357017 hydrochloride can be used for the research of Alzheimer’s disease and schizophrenia[1][2][3].

   

10-hydroxy-5-methyl-12-methylidene-3-oxo-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-18-yl acetate

10-hydroxy-5-methyl-12-methylidene-3-oxo-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-18-yl acetate

C22H27NO4 (369.19399820000007)


   

(12br,13r)-3,4,10,11-tetramethoxy-13-methyl-7,8,12b,13-tetrahydro-5h-6-azatetraphene

(12br,13r)-3,4,10,11-tetramethoxy-13-methyl-7,8,12b,13-tetrahydro-5h-6-azatetraphene

C22H27NO4 (369.19399820000007)


   

10-ethyl-14-methyl-3-(4-methyl-5-oxooxolan-2-yl)-12-oxa-4-azatetracyclo[7.6.1.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(16),2,8-trien-13-one

10-ethyl-14-methyl-3-(4-methyl-5-oxooxolan-2-yl)-12-oxa-4-azatetracyclo[7.6.1.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(16),2,8-trien-13-one

C22H27NO4 (369.19399820000007)


   

2-[(2-amino-1-hydroxypropylidene)amino]-3-[2-({hydroxy[4-oxo-3-(sec-butyl)oxetan-2-yl]methylidene}amino)cyclopropyl]propanoic acid

2-[(2-amino-1-hydroxypropylidene)amino]-3-[2-({hydroxy[4-oxo-3-(sec-butyl)oxetan-2-yl]methylidene}amino)cyclopropyl]propanoic acid

C17H27N3O6 (369.1899762)


   

(2r)-2-{[(3ar,8as)-3a-hydroxy-2h,3h,8ah-furo[2,3-b]indol-8-yl]methyl}-4-butyl-2,5-dimethylcyclopent-4-ene-1,3-dione

(2r)-2-{[(3ar,8as)-3a-hydroxy-2h,3h,8ah-furo[2,3-b]indol-8-yl]methyl}-4-butyl-2,5-dimethylcyclopent-4-ene-1,3-dione

C22H27NO4 (369.19399820000007)


   

(2s)-2-{[(3ar)-3a-hydroxy-2h,3h,8ah-furo[2,3-b]indol-8-yl]methyl}-4-butyl-2,5-dimethylcyclopent-4-ene-1,3-dione

(2s)-2-{[(3ar)-3a-hydroxy-2h,3h,8ah-furo[2,3-b]indol-8-yl]methyl}-4-butyl-2,5-dimethylcyclopent-4-ene-1,3-dione

C22H27NO4 (369.19399820000007)


   

7-(2-hydroxyethyl)-5-methyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-6,16,19-trione

7-(2-hydroxyethyl)-5-methyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-6,16,19-trione

C22H27NO4 (369.19399820000007)


   

(1r,5r,8r,9s,10r,11s,14s,16s,17r,18s)-10-hydroxy-5-methyl-12-methylidene-3-oxo-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-18-yl acetate

(1r,5r,8r,9s,10r,11s,14s,16s,17r,18s)-10-hydroxy-5-methyl-12-methylidene-3-oxo-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-18-yl acetate

C22H27NO4 (369.19399820000007)


   

(1s,2s,5r,6r,10s,12s,13r,16r,18s)-6,9-dihydroxy-5,12,16-trimethyl-8-azapentacyclo[10.8.0.0²,¹⁰.0⁶,¹⁰.0¹³,¹⁸]icosa-3,8,19-triene-7,11-dione

(1s,2s,5r,6r,10s,12s,13r,16r,18s)-6,9-dihydroxy-5,12,16-trimethyl-8-azapentacyclo[10.8.0.0²,¹⁰.0⁶,¹⁰.0¹³,¹⁸]icosa-3,8,19-triene-7,11-dione

C22H27NO4 (369.19399820000007)


   

(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-3-[(1s,2s)-2-({[(2r)-3-[(2s)-butan-2-yl]-4-oxooxetan-2-yl](hydroxy)methylidene}amino)cyclopropyl]propanoic acid

(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-3-[(1s,2s)-2-({[(2r)-3-[(2s)-butan-2-yl]-4-oxooxetan-2-yl](hydroxy)methylidene}amino)cyclopropyl]propanoic acid

C17H27N3O6 (369.1899762)


   
   

(10s,11r,14r,15s)-10-ethyl-14-methyl-3-[(2r,4r)-4-methyl-5-oxooxolan-2-yl]-12-oxa-4-azatetracyclo[7.6.1.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(16),2,8-trien-13-one

(10s,11r,14r,15s)-10-ethyl-14-methyl-3-[(2r,4r)-4-methyl-5-oxooxolan-2-yl]-12-oxa-4-azatetracyclo[7.6.1.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(16),2,8-trien-13-one

C22H27NO4 (369.19399820000007)


   

(1r,5s,8r,9s,10s,11s,14s,16s,17r,18s)-10-hydroxy-5-methyl-12-methylidene-3-oxo-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-18-yl acetate

(1r,5s,8r,9s,10s,11s,14s,16s,17r,18s)-10-hydroxy-5-methyl-12-methylidene-3-oxo-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-18-yl acetate

C22H27NO4 (369.19399820000007)


   
   

6-(1h-indol-3-ylmethyl)-3-isopropyl-5-[(1e)-2-phenylethenyl]-1h-pyrazin-2-one

6-(1h-indol-3-ylmethyl)-3-isopropyl-5-[(1e)-2-phenylethenyl]-1h-pyrazin-2-one

C24H23N3O (369.1841028)


   

(1s,5r,8r,9s,11r,14s,17s,18r)-7-(2-hydroxyethyl)-5-methyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-6,16,19-trione

(1s,5r,8r,9s,11r,14s,17s,18r)-7-(2-hydroxyethyl)-5-methyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-6,16,19-trione

C22H27NO4 (369.19399820000007)


   

dimethyl[2-(3,4,7,8-tetramethoxyphenanthren-1-yl)ethyl]amine

dimethyl[2-(3,4,7,8-tetramethoxyphenanthren-1-yl)ethyl]amine

C22H27NO4 (369.19399820000007)


   

6-(1h-indol-3-ylmethyl)-3-isopropyl-5-[(1z)-2-phenylethenyl]-1h-pyrazin-2-one

6-(1h-indol-3-ylmethyl)-3-isopropyl-5-[(1z)-2-phenylethenyl]-1h-pyrazin-2-one

C24H23N3O (369.1841028)


   

1-[4-hydroxy-3-methoxy-2-methyl-6-(3-methylbut-2-en-1-yl)-9h-carbazol-1-yl]propane-1,2-diol

1-[4-hydroxy-3-methoxy-2-methyl-6-(3-methylbut-2-en-1-yl)-9h-carbazol-1-yl]propane-1,2-diol

C22H27NO4 (369.19399820000007)


   

dimethyl[2-(3,4,6,7-tetramethoxyphenanthren-1-yl)ethyl]amine

dimethyl[2-(3,4,6,7-tetramethoxyphenanthren-1-yl)ethyl]amine

C22H27NO4 (369.19399820000007)


   

(12br)-3,4,10,11-tetramethoxy-13-methyl-7,8,12b,13-tetrahydro-5h-6-azatetraphene

(12br)-3,4,10,11-tetramethoxy-13-methyl-7,8,12b,13-tetrahydro-5h-6-azatetraphene

C22H27NO4 (369.19399820000007)


   

(2s)-2-{[(3ar,8as)-3a-hydroxy-2h,3h,8ah-furo[2,3-b]indol-8-yl]methyl}-4-butyl-2,5-dimethylcyclopent-4-ene-1,3-dione

(2s)-2-{[(3ar,8as)-3a-hydroxy-2h,3h,8ah-furo[2,3-b]indol-8-yl]methyl}-4-butyl-2,5-dimethylcyclopent-4-ene-1,3-dione

C22H27NO4 (369.19399820000007)


   

21-hydroxy-5-methyl-15-methylidene-7-oxa-10-azaheptacyclo[12.6.2.0¹,¹¹.0⁵,²⁰.0⁶,¹⁰.0¹²,¹⁷.0¹⁷,²¹]docosane-19,22-dione

21-hydroxy-5-methyl-15-methylidene-7-oxa-10-azaheptacyclo[12.6.2.0¹,¹¹.0⁵,²⁰.0⁶,¹⁰.0¹²,¹⁷.0¹⁷,²¹]docosane-19,22-dione

C22H27NO4 (369.19399820000007)


   

4-(hydroxymethyl)-7-methyl-8-[3-methyl-3-(3-methylbutyl)oxiran-2-yl]-9h-carbazole-1,6-diol

4-(hydroxymethyl)-7-methyl-8-[3-methyl-3-(3-methylbutyl)oxiran-2-yl]-9h-carbazole-1,6-diol

C22H27NO4 (369.19399820000007)


   

2-({3a-hydroxy-2h,3h,8ah-furo[2,3-b]indol-8-yl}methyl)-4-butyl-2,5-dimethylcyclopent-4-ene-1,3-dione

2-({3a-hydroxy-2h,3h,8ah-furo[2,3-b]indol-8-yl}methyl)-4-butyl-2,5-dimethylcyclopent-4-ene-1,3-dione

C22H27NO4 (369.19399820000007)


   

(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-3-[(1r,2s)-2-({hydroxy[(3s)-4-oxo-3-(sec-butyl)oxetan-2-yl]methylidene}amino)cyclopropyl]propanoic acid

(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-3-[(1r,2s)-2-({hydroxy[(3s)-4-oxo-3-(sec-butyl)oxetan-2-yl]methylidene}amino)cyclopropyl]propanoic acid

C17H27N3O6 (369.1899762)


   

(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-3-[(1r,2s)-2-({[(2r,3s)-3-[(2s)-butan-2-yl]-4-oxooxetan-2-yl](hydroxy)methylidene}amino)cyclopropyl]propanoic acid

(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-3-[(1r,2s)-2-({[(2r,3s)-3-[(2s)-butan-2-yl]-4-oxooxetan-2-yl](hydroxy)methylidene}amino)cyclopropyl]propanoic acid

C17H27N3O6 (369.1899762)